UW's vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.

UPMC Enterprises has contributed to a $117m series B round for gene therapy developer Ring Therapeutics.

Mitsui and Nan Fung are among the backers celebrating Rallybio’s flotation on the Nasdaq Global Select Market following an $80.6m offering.

The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.

The Sanofi Ventures-backed vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

The ultrasound imaging technology developer backed by multiple corporates has completed a series C round that brought its overall funding to $320m.

Existing investors Pfizer Ventures and Merck GHI helped the precision cancer test developer take its total funding past the $130m mark.

IN8Bio, a University of Alabama spinout and cancer immunotherapy developer, has pulled in $40m through its IPO.

SoftBank-backed barbershop booking service Squire raised $60m at a $750m valuation while card issuing platform developer Lithic was valued at $800m in a round featuring Exor.